Expert Antibody Conversion Services

This is where Antibody Conversion, a cornerstone of modern antibody engineering, becomes transformative. Antibody Conversion, also known as antibody reformatting, is the strategic application of recombinant DNA technology to modify the structure of an antibody. This process allows for the precise exchange, addition, or deletion of antibody domains, effectively "converting" an antibody from one format to another while preserving its critical antigen-binding specificity. For over two decades, Creative Biolabs has stood at the forefront of antibody engineering. We empower researchers by transforming their foundational antibodies into powerful, application-ready tools. Our comprehensive Antibody Conversion Services provide a flexible, high-throughput platform to re-engineer virtually any antibody format, enabling you to overcome research limitations, unlock new therapeutic modalities, and accelerate your path to discovery.

Discuss Your Project Today

The Strategic Imperative: Why Reformat Your Antibody?

An antibody's format dictates its function. The isotype (e.g., IgG, IgA, IgM) determines its effector functions and half-life, while its species of origin dictates its immunogenic potential. Converting your antibody is not merely a technical step; it is a strategic decision to optimize your molecule for its specific biological and experimental context.

• Accelerate Therapeutic Development: The journey from a mouse hybridoma "hit" to a clinical "lead" is defined by conversion. Our services, particularly chimerization and humanization, are essential for reducing the immunogenicity that causes anti-drug antibody (ADA) responses in patients. Further engineering, such as isotype switching (e.g., to IgG4 for tolerance or IgG1 for ADCC) or conversion to a bispecific format, is critical for creating next-generation biologics.
• Enhance Diagnostic Assays: Standard IgGs can be cumbersome for certain diagnostic platforms. Converting an IgG to a smaller Fab or scFv fragment can improve tissue penetration in IHC or enable site-specific conjugation. Switching to an IgM can dramatically increase avidity in agglutination assays, while converting to IgA is ideal for developing mucosal diagnostics.
• Unlock Research Versatility: Is your favorite primary antibody only available as a mouse IgG1, complicating your dual-labeling immunofluorescence with other mouse antibodies? We can seamlessly convert it to a rabbit IgG or a different mouse subclass. Need to perform structural biology? We can convert your full-length antibody into a Fab fragment for crystallization. Developing a CAR-T construct? We provide the essential scFv conversion to build your chimeric antigen receptor.

Our antibody conversion platform eliminates these roadblocks, providing you with a fit-for-purpose molecule designed for success.

Fig. 1 Types of antibodies.

Our Comprehensive Antibody Conversion Service Portfolio

Creative Biolabs offers a "sequence-to-protein" service, capable of starting from your provided antibody sequence, hybridoma cell line, or even purified protein. We handle everything: in silico design, gene synthesis, vector construction, expression, purification, and stringent QC.

Antibody Isotype Switching & Subclass Conversion

Our isotype switching service allows you to modulate the antibody's biological activity without altering its binding target. We maintain the original variable (V) regions and precisely clone them onto a new constant (C) region backbone of your choice.

• Human: IgG1, IgG2, IgG3, IgG4, IgA1, IgA2, IgE, IgM, IgD
• Mouse: IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgA, IgM
• Other Species: Rabbit IgG, Rat IgG, Hamster IgG, Rhesus Macaque IgG, and more.

This service is ideal for creating matched isotype controls, exploring different effector mechanisms (ADCC/CDC), or adapting an antibody for specific detection reagents.

Antibody Species Conversion

To reduce the immunogenicity of non-human antibodies for pre-clinical and therapeutic applications, species conversion is essential.

• Humanization (Convert to Human Ab): The gold standard for therapeutic development. This complex antibody engineering process involves grafting only the non-human Complementarity Determining Regions (CDRs)—the hypervariable loops responsible for binding—onto a human variable region framework. Our proprietary in silico and structure-guided platforms ensure optimal CDR grafting and critical back-mutations to retain or even enhance the original affinity. The final humanized antibody is >90% human.
• Camelization (Convert to Single-Domain Ab): Converting conventional antibodies into single-domain antibodies (sdAbs) for improved tissue penetration and stability.
• Caninization (Convert to Dog Ab): Adapting antibodies for use in canine models, preserving function and compatibility for veterinary applications.
• Simianization (Convert to NHP Ab): Converting antibodies into forms suitable for non-human primates (NHP).
• Murinization (Convert to Mouse Ab): Modifying antibodies for expression and testing in murine models.
• Felinization (Convert to Cat Ab): Converting antibodies for feline models to enable diagnostics and therapeutics for cats.

Antibody Fragment Reformatting & Conversion

Full-length IgGs are not always optimal. Smaller fragments offer unique advantages, including improved tissue penetration, access to cryptic epitopes, and reduced non-specific binding. We are experts in converting full-length antibodies into a wide array of functional fragments.

• scFv (Single-Chain Variable Fragment): The VH and VL domains joined by a flexible peptide linker. Essential for phage display libraries and CAR-T cell therapy constructs.
• Fab (Fragment, antigen-binding): A single "arm" of the antibody (VH-CH1 and VL-CL). Monovalent binding is perfect for structural biology (crystallography) and fine-tuning affinity studies.
• F(ab')2: Two Fab arms linked by a disulfide bond, retaining bivalent binding without the Fc region.
• V_HH (Single Domain Antibody): Reformatting of heavy-chain-only antibodies.

Full-Length Antibody Reconstruction from Fragments

The workflow also runs in reverse. If you have identified a promising binder from a phage display library (e.g., an scFv or Fab), we can reformat it back into a full-length, bivalent IgG (or any other isotype) for in vivo studies, benefiting from the stability, half-life, and effector functions of the Fc domain.

Bispecific & Multispecific Antibody Conversion

Leverage the power of dual-targeting. Our advanced antibody engineering platform can convert two (or more) separate monoclonal antibodies into a single bispecific antibody (BsAb) construct. We can take the variable domains from your existing antibodies and reformat them into dozens of clinically-relevant formats.

This service is at the cutting edge of developing novel therapeutics that can bridge immune cells to tumor cells or simultaneously block two disease pathways.

Our Advanced Antibody Conversion Technology Platform

Success in antibody reformatting requires more than just cloning. It demands a synergistic platform of computational biology, molecular biology, and protein science.

In Silico Design & Antibody Sequence Optimization

Every project begins with advanced computational design. Our bioinformatics team utilizes proprietary algorithms to:

• De-immunize sequences and predict immunogenicity hotspots.
• Model CDR structures for high-fidelity humanization.
• Analyze framework-CDR interactions to ensure affinity is retained.
• Optimize codon usage for the target expression host (e.g., CHO, HEK293, E. coli), ensuring maximal protein yield.

High-Throughput Gene Synthesis & Vector Construction

We eliminate the bottleneck of traditional cloning. Our high-throughput gene synthesis platform allows us to rapidly produce sequence-verified, 100% accurate synthetic genes for your new antibody chains (VH, VL, C-regions). These are then cloned into our extensive library of proprietary expression vectors, which are optimized for high-yield transient or stable expression.

Multi-System Recombinant Expression & Production

No single expression system is perfect for all antibody formats. Our platform provides the flexibility to choose the ideal host for your specific converted antibody.

• Mammalian Expression (HEK293 & CHO): The gold standard for full-length IgGs, IgAs, IgMs, and complex bispecifics. This system provides human-like post-translational modifications, including critical glycosylation for effector function. We offer transient expression for rapid (mg-scale) production and stable cell line development for long-term (g-scale) needs.
• Bacterial Expression (E. coli): The most cost-effective and rapid system for producing smaller, non-glycosylated fragments like scFv, Fab, and V_HH.
• Yeast Expression (P. pastoris): A robust, scalable system that offers a balance of speed and simple eukaryotic modifications.

State-of-the-Art Purification & Analytical QC

A converted antibody is only as good as its purity and functional validation. Every project concludes with a rigorous QC package.

• Purification: We employ multi-step purification strategies (e.g., Protein A/G/L affinity, IEX, SEC) to deliver >95% purity.
• Analytics: Standard delivery includes SDS-PAGE (purity, integrity), SEC-HPLC (aggregation), and LAL testing (endotoxin).
• Functional Validation (Optional): We strongly recommend validating your converted antibody's binding affinity using ELISA, SPR (Biacore), or BLI (Octet) to confirm it retains the potency of the parent molecule.

The Creative Biolabs Advantage: Your Partner in Antibody Engineering

Choosing Creative Biolabs for your antibody conversion project ensures a seamless, reliable, and scientifically-sound partnership.

• Decades of Experience: With over 20 years dedicated to antibody engineering, we have successfully completed tens of thousands of complex conversion projects.
• Comprehensive "Any-to-Any" Platform: From any starting material to any desired format, we are your "one-stop shop" for all antibody reformatting needs.
• Speed and Flexibility: Our high-throughput gene synthesis and transient expression platforms deliver your converted antibodies in weeks, not months.
• Scientific Consultation: You are not just ordering a product; you are gaining a partner. Our Ph.D.-level specialists consult with you to design the optimal construct for your goals.
• Proven Track Record: Our platforms have delivered high-quality antibodies that are now part of our clients' pre-clinical candidates, diagnostic kits, and high-impact publications.
• Strict Quality Assurance: We guarantee the sequence, purity, and low endotoxin levels of your final product, ensuring your experiments are built on a foundation of quality.

Explore Our Comprehensive Services

We offer a comprehensive range of customizable antibody property optimization services to ensure that each antibody achieves the highest standards in terms of efficacy, stability, and safety, empowering your research with tailored solutions to accelerate development.

• Antibody Humanization (Convert to Human Ab)
• Antibody Camelization (Convert to Single Domain Ab)
• Antibody Caninization (Convert to Dog Ab)
• Antibody Simianization (Convert to NHP Ab)
• Antibody Murinization (Convert to Mouse Ab)
• Antibody Felinization (Convert to Cat Ab)
• Affinity Maturation
• Stability Improvement
• Specificity Optimization
• Cysteine Modification
• T Cell Receptor Engineering
• Protein Engineering

Don't let the wrong antibody format limit your research. Partner with the antibody engineering experts at Creative Biolabs to convert your promising binder into a powerful, application-ready tool.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: What do I need to provide to start an antibody conversion project?

A: The fastest and most cost-effective starting material is the antibody's variable region sequences (VH and VL). However, we can also start from hybridoma cell lines or purified antibody protein; this would simply require our De Novo Antibody Sequencing Service as a first step.

Q: How do you guarantee the converted antibody will be functional and bind its target?

A: We guarantee that the final antibody protein will have the exact amino acid sequence you approved and will meet all QC specifications for purity and aggregation. While our advanced in silico design platforms are optimized to preserve CDR conformation, the binding affinity is an intrinsic property of the V-region sequence. We highly recommend adding functional validation (e.g., ELISA, SPR, or BLI) to your project to empirically confirm the binding affinity of the newly formatted antibody.

Q: What is the main difference between your chimerization and humanization services?

A: Chimerization involves fusing the entire non-human variable region (VH and VL) to a human constant region. The resulting antibody is ~66% human. Humanization is a more complex process where only the CDRs (the binding loops, ~5-10% of the antibody) are grafted onto human framework regions. The final antibody is >90% human and carries a much lower risk of immunogenicity, making it the preferred choice for therapeutics.

Q: Can you convert my mouse IgG1 to a human IgA2?

A: Absolutely. This is a common request that combines two of our services: species conversion (mouse-to-human) and isotype switching (IgG-to-IgA). Our platform is designed to handle such multi-step conversions seamlessly.

Q: Are these converted antibodies suitable for clinical use?

A: All services and products described on this page are provided For Research Use Only (RUO). They are not intended for use in clinical diagnostic procedures or for therapeutic use in humans. Please inquire with our team about our cGMP-compliant manufacturing services for clinical-grade materials.